Antimicrobial resistance in tuberculosis: an international perspective

References

• Mitchison DA. Development of streptomycin resistant strains of tubercle bacilli in pulmonary tuberculosis; results of simultaneous sensitivity tests in liquid and on solid media. Thorax5(2), 144–161 (1950).
   PubMedGoogle Scholar
• David HL. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Appl. Microbiol.20(5), 810–814 (1970).
   PubMedGoogle Scholar
• Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol.36(7), 1969–1973 (1998).
   PubMed Web of Science ®Google Scholar
• Streicher EM, Warren RM, Kewley C et al. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J. Clin. Microbiol.42(2), 891–894 (2004).
   PubMedGoogle Scholar
• Victor TC, Lee H, Cho SN et al. Molecular detection of early appearance of drug resistance during Mycobacterium tuberculosis infection. Clin. Chem. Lab. Med.40(9), 876–881 (2002).
   PubMedGoogle Scholar
• van Rie A, Warren R, Mshanga I et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol.39(2), 636–641 (2001).
   PubMed Web of Science ®Google Scholar
• Mitchison DA. How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis. Int. J. Tuberc. Lung Dis.2(1), 10–15 (1998).
   PubMed Web of Science ®Google Scholar
• Dooley SW, Simone PM. The extent and management of drug-resistant tuberculosis: the American experience. Clinical tuberculosis Chapman & Hall, London, UK 171–189 (1994).
   Google Scholar
• Farmer P, Walton D. The social impact of multi-drug-resistant tuberculosis: Haiti and Peru. In: The Return of the White Plague. Gandy M, Zumla A (Eds). Verso, London, UK 163–177 (2003).
   Google Scholar
• Espinal MA, Kim SJ, Suarez PG et al. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA283(19), 2537–2545 (2000).
   PubMed Web of Science ®Google Scholar
• Weyer K, Kleeberg HH. Primary and acquired drug resistance in adult black patients with tuberculosis in South Africa: results of a continuous national drug resistance surveillance programme involvement. Tuber. Lung Dis.73(2), 106–112 (1992).
   PubMedGoogle Scholar
• Kim SJ, Bai GH, Hong YP. Drug-resistant tuberculosis in Korea, 1994. Int. J. Tuberc. Lung Dis.1(4), 302–308 (1997).
   PubMed Web of Science ®Google Scholar
• Andersson DI, Levin BR. The biological cost of antibiotic resistance. Curr. Opin. Microbiol.2(5), 489–493 (1999).
   PubMed Web of Science ®Google Scholar
• Mariam DH, Mengistu Y, Hoffner SE, Andersson DI. Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis. Antimicrob. Agents Chemother.48(4), 1289–1294 (2004).
   PubMed Web of Science ®Google Scholar
• Streicher EM, Warren RM, Kewley C et al. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J. Clin. Microbiol.42(2), 891–894 (2004).
   PubMedGoogle Scholar
• Espinal MA. Time to abandon the standard retreatment regimen with first-line drugs for failures of standard treatment. Int. J. Tuberc. Lung Dis.7(7), 607–608 (2003).
   PubMedGoogle Scholar
• Deriemer K, Garcia-Garcia L, Bobadilla-del-Valle M et al. Does DOTS work in populations with drug-resistant tuberculosis? Lancet365(9466), 1239–1245 (2005).
   PubMed Web of Science ®Google Scholar
• Suarez PG, Floyd K, Portocarrero J et al. Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet359(9322), 1980–1989 (2002).
   PubMed Web of Science ®Google Scholar
• Van Deun A, Salim MA, Das AP, Bastian I, Portaels F. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh. Int. J. Tuberc. Lung Dis.8(5), 560–567 (2004).
   PubMed Web of Science ®Google Scholar
• Tinne JE, Henderson JL. Primary streptomycin-resistant tuberculosis in a newborn child. Simple method of assessing streptomycin resistance. Lancet2(27), 901–904 (1950).
   PubMedGoogle Scholar
• Zitrin CM, Lincoln EM. Initial tuberculous infection due to drug-resistant organisms. With a review of the world literature on initial infection due to isoniazid-resistant tubercle bacilli. J. Pediatr.58, 219–225 (1961).
   PubMedGoogle Scholar
• Steiner P, Rao M, Mitchell M, Steiner M. Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampin. Am. Rev. Respir. Dis.134(3), 446–448 (1986).
   PubMedGoogle Scholar
• Schaaf HS, Vermeulen HA, Gie RP, Beyers N, Donald PR. Evaluation of young children in household contact with adult multidrug-resistant pulmonary tuberculosis cases. Pediatr. Infect. Dis. J.18(6), 494–500 (1999).
   PubMed Web of Science ®Google Scholar
• Schaaf HS, Gie RP, Kennedy M, Beyers N, Hesseling PB, Donald PR. Evaluation of young children in contact with adult multidrug-resistant pulmonary tuberculosis: a 30-month follow-up. Pediatrics109(5), 765–771 (2002).
   PubMed Web of Science ®Google Scholar
• van Rie A, Warren R, Richardson M et al. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment. N. Engl. J. Med.341(16), 1174–1179 (1999).
   PubMed Web of Science ®Google Scholar
• Verver S, Warren RM, Beyers N et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am. J. Respir. Crit. Care Med.171(12), 1430–1435 (2005).
   PubMed Web of Science ®Google Scholar
• Wayne LG, Sohaskey CD. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol.55, 139–163 (2001).
   PubMed Web of Science ®Google Scholar
• Mitchison DA, Coates AR. Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugs. Curr. Pharm. Des.10(26), 3285–3295 (2004).
   PubMed Web of Science ®Google Scholar
• Moore DA, Mendoza D, Gilman RH et al. Microscopic observation drug susceptibility assay, a rapid, reliable diagnostic test for multidrug-resistant tuberculosis suitable for use in resource-poor settings. J. Clin. Microbiol.42(10), 4432–4437 (2004).
   PubMed Web of Science ®Google Scholar
• Victor TC, van Helden PD, Warren R. Prediction of drug resistance in M. tuberculosis: molecular mechanisms, tools, and applications. IUBMB Life53(4–5), 231–237 (2002).
   PubMed Web of Science ®Google Scholar
• Johnson R, Jordaan AM, Pretorius L et al. Ethambutol resistance testing by mutation detection. Int. J. Tuberc. Lung Dis.10(1), 68–73 (2006).
   PubMedGoogle Scholar
• Louw GE, Warren RM, Donald PR et al. Frequency and implications of pyrazinamide resistance in managing previously treated tuberculosis patients. Int. J. Tuberc. Lung Dis.10(7), 802–807 (2006).
   PubMed Web of Science ®Google Scholar
• van Rie A, Warren R, Richardson M et al. Classification of drug-resistant tuberculosis in an epidemic area. Lancet356(9223), 22–25 (2000).
   PubMedGoogle Scholar
• Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature438(7066), 355–359 (2005).
   PubMed Web of Science ®Google Scholar
• Park H, Song EJ, Song ES et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J. Clin. Microbiol.44(5), 1619–1624 (2006).
   PubMed Web of Science ®Google Scholar
• Vernet G, Jay C, Rodrigue M, Troesch A. Species differentiation and antibiotic susceptibility testing with DNA microarrays. J. Appl. Microbiol.96(1), 59–68 (2004).
   PubMedGoogle Scholar
• Watterson SA, Wilson SM, Yates MD, Drobniewski FA. Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J. Clin. Microbiol.36(7), 1969–1973 (1998).
   PubMed Web of Science ®Google Scholar
• van Rie A, Warren R, Mshanga I et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol.39(2), 636–641 (2001).
   PubMed Web of Science ®Google Scholar
• Maher D, Raviglione M. Global epidemiology of tuberculosis. Clin. Chest Med.26(2), 167–182 (2005).
   PubMedGoogle Scholar
• Cohen T, Murray M. Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness. Nat. Med.10(10), 1117–1121 (2004).
   PubMed Web of Science ®Google Scholar
• Blower SM, Chou T. Modeling the emergence of the ‘hot zones’: tuberculosis and the amplification dynamics of drug resistance. Nat. Med.10(10), 1111–1116 (2004).
   PubMed Web of Science ®Google Scholar